OmniActive’s Lutemax 2020 showed increases in macular pigment density (MPOD)—the thickness of the macular pigment which is made up of lutein (L) and zeaxanthin isomers (Zi) which lead to significant improvements in photostress recovery and disability glare in a recent study conducted at the University of Georgia entitled LAMA II—an acronym for Lutein, Vision and Mental Acuity II.